R Gross

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women
    Livio Azzoni
    The Wistar Institute, Philadelphia, PA, USA
    J Int AIDS Soc 13:33. 2010
  2. ncbi request reprint Impact of a hospital-based antimicrobial management program on clinical and economic outcomes
    R Gross
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Dr, Philadelphia, PA 19104, USA
    Clin Infect Dis 33:289-95. 2001
  3. ncbi request reprint A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression
    Robert Gross
    Division of Infectious Diseases, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, Center for Education and Research in Therapeutics, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    J Infect Dis 194:1108-14. 2006
  4. ncbi request reprint Medication refill logistics and refill adherence in HIV
    R Gross
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 14:789-93. 2005
  5. ncbi request reprint A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV
    Robert Grossberg
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Epidemiol 57:1107-10. 2004
  6. ncbi request reprint Effect of adherence to newly initiated antiretroviral therapy on plasma viral load
    R Gross
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6021, USA
    AIDS 15:2109-17. 2001
  7. ncbi request reprint A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia
    Valerianna Amorosa
    Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA 19104 6073, USA
    J Acquir Immune Defic Syndr 39:557-61. 2005
  8. ncbi request reprint Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy
    Gregory P Bisson
    Department of Medicine, Division of Infectious Diseases, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104 6021, USA
    AIDS 20:1613-9. 2006
  9. pmc Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence
    Trisha Acri
    Department of Family and Community Medicine, Temple University, Philadelphia, PA 19140, USA
    AIDS Behav 14:748-54. 2010
  10. ncbi request reprint Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression
    Emmanouil Papasavvas
    The Wistar Institute, Philadelphia, USA
    J Infect Dis 188:873-82. 2003

Research Grants

  1. ADHERENCE TO PROTEASE INHIBITORS IN HIV
    Robert Gross; Fiscal Year: 2003
  2. Pharmacogenetics and HIV treatment outcomes
    Robert Gross; Fiscal Year: 2009
  3. Managed problem solving: An HIV adherence trial
    Robert Gross; Fiscal Year: 2009
  4. Pharmacogenetics and HIV treatment outcomes
    Robert Gross; Fiscal Year: 2010
  5. Pharmacogenetics and HIV treatment outcomes
    Robert Gross; Fiscal Year: 2010

Detail Information

Publications46

  1. pmc Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women
    Livio Azzoni
    The Wistar Institute, Philadelphia, PA, USA
    J Int AIDS Soc 13:33. 2010
    ..Advanced HIV infection can result in lipoatrophy and wasting, even in the absence of ongoing opportunistic infections, suggesting that HIV may directly affect adipose tissue amount and distribution...
  2. ncbi request reprint Impact of a hospital-based antimicrobial management program on clinical and economic outcomes
    R Gross
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Dr, Philadelphia, PA 19104, USA
    Clin Infect Dis 33:289-95. 2001
    ..In an academic setting with a restricted formulary, the AMT demonstrated better antimicrobial prescribing than ID fellows...
  3. ncbi request reprint A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression
    Robert Gross
    Division of Infectious Diseases, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, Center for Education and Research in Therapeutics, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    J Infect Dis 194:1108-14. 2006
    ....
  4. ncbi request reprint Medication refill logistics and refill adherence in HIV
    R Gross
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 14:789-93. 2005
    ..The relation between pharmacy-based factors and treatment adherence has been under-explored. We aimed to determine whether different medication refill mechanisms were associated with differences in antiretroviral refill adherence...
  5. ncbi request reprint A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV
    Robert Grossberg
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Epidemiol 57:1107-10. 2004
    ..The goal of this study was to determine the validity and utility of a pharmacy-based time-to-refill measure of antiretroviral therapy adherence...
  6. ncbi request reprint Effect of adherence to newly initiated antiretroviral therapy on plasma viral load
    R Gross
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6021, USA
    AIDS 15:2109-17. 2001
    ..To determine whether differences in adherence to newly initiated antiretroviral therapy exist between subjects who do and do not achieve undetectable plasma viral loads...
  7. ncbi request reprint A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia
    Valerianna Amorosa
    Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA 19104 6073, USA
    J Acquir Immune Defic Syndr 39:557-61. 2005
    ..Obesity and HIV infection are ongoing epidemics in the United States. Obesity predisposes to diabetes and cardiovascular disease, which are complications also associated with HIV and/or its treatment...
  8. ncbi request reprint Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy
    Gregory P Bisson
    Department of Medicine, Division of Infectious Diseases, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104 6021, USA
    AIDS 20:1613-9. 2006
    ..To derive and internally validate a clinical prediction rule for virologic response based on CD4 cell count increase after initiation of HAART in a resource-limited setting...
  9. pmc Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence
    Trisha Acri
    Department of Family and Community Medicine, Temple University, Philadelphia, PA 19140, USA
    AIDS Behav 14:748-54. 2010
    ..Reassessment of the relation between pharmacy refill data and EDM would be warranted when pharmacy refill data is collected as soon as feasible from sources with complete data capture...
  10. ncbi request reprint Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression
    Emmanouil Papasavvas
    The Wistar Institute, Philadelphia, USA
    J Infect Dis 188:873-82. 2003
    ..Overall, a history of stable CD4(+) T cell counts, as a result of therapy that imparted full or partial virus suppression, was associated with increased levels of anti-HIV CD4(+) T helper responses and decreased T cell activation...
  11. ncbi request reprint HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption
    Emmanouil Papasavvas
    The Wistar Institute, Philadelphia, Pennsylvania 19104, USA
    J Clin Immunol 26:40-54. 2006
    ..04) with no difference between groups by week 24. These data support that blippers have higher anti-HIV lymphoproliferative responses while on ART but experience equal to higher viral rebound as compared to matched non-blippers upon TI...
  12. pmc Overestimates of survival after HAART: implications for global scale-up efforts
    Gregory P Bisson
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    PLoS ONE 3:e1725. 2008
    ..Determining definitive outcomes of these lost patients, and the effects of losses to follow-up on estimates of survival and risk factors for death after HAART, are key to monitoring the effectiveness of global HAART scale-up efforts...
  13. pmc Risk factors for nonadherence to warfarin: results from the IN-RANGE study
    Alec B Platt
    Department of Medicine, University of Pennsylvania School of Medicine, PA, USA
    Pharmacoepidemiol Drug Saf 17:853-60. 2008
    ..Warfarin is widely used to prevent stroke and venous thromboembolism despite its narrow therapeutic window. Warfarin nonadherence is a substantial problem, but risk factors have not been well elucidated...
  14. ncbi request reprint HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time
    William C Holmes
    Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA
    J Acquir Immune Defic Syndr 46:323-7. 2007
    ..To determine if HIV/AIDS-specific quality of life (QOL) predicts adherence to antiretroviral therapy (ART)...
  15. ncbi request reprint Predicting and monitoring antiretroviral adherence
    Robert Gross
    Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
    LDI Issue Brief 13:1-4. 2007
    ..This Issue Brief summarizes recent studies whose findings may help clinicians predict and monitor their patients' adherence before treatment failure occurs...
  16. doi request reprint Validity and comparison of two measures of days supply in Medicaid claims data
    Robert Gross
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 17:1029-32. 2008
    ..The two measures should yield the same duration, but if not, the preferred method is unknown...
  17. pmc Incidence of transaminitis among HIV-infected patients with occult hepatitis B
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Virol 43:32-6. 2008
    ..This information is needed to determine the importance of detecting and treating occult HBV in this population...
  18. pmc Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
    Alec B Platt
    MSCE, University of Pennsylvania School of Medicine, 707 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104 6021, USA
    Chest 137:883-9. 2010
    ..Currently, no comprehensive screening tool exists to help providers assess the risk of nonadherence at the time of initiation of warfarin therapy...
  19. doi request reprint How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?
    Robert Gross
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6021, USA
    HIV Clin Trials 9:202-6. 2008
    ..The time between onset of nonadherence and onset of virological failure is unknown. However, this information is critical to the design, implementation, and testing of interventions aiming to forestall treatment failure...
  20. doi request reprint Untreated hypertension and the emergency department: a chance to intervene?
    Craig A Umscheid
    Center for Clinical Epidemiology and Biostatistics, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Acad Emerg Med 15:529-36. 2008
    ..The authors investigated the accuracy of identifying HTN in the ED, the proportion of ED patients with untreated HTN, patient characteristics predicting untreated HTN, and provider documentation of untreated HTN...
  21. doi request reprint Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana
    Gregory P Bisson
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Acquir Immune Defic Syndr 49:107-10. 2008
    ..Although adherence to antiretroviral therapy may be higher in sub-Saharan Africa, knowledge regarding the magnitude of adherence needed to maintain virological suppression in this setting is limited...
  22. pmc Adherence to hepatitis C virus therapy and early virologic outcomes
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Dr, Philadelphia, PA 19104 6021, USA
    Clin Infect Dis 48:186-93. 2009
    ..We examined the relationship between adherence to pegylated interferon and ribavirin therapy, measured by pharmacy refill, and HCV suppression during the initial 12 weeks of therapy...
  23. ncbi request reprint The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
    Stephen E Kimmel
    Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    Arch Intern Med 167:229-35. 2007
    ..Warfarin sodium is a highly efficacious drug, but proper levels of anticoagulation are difficult to maintain. Conflicting data exist on the influence of patient adherence on anticoagulation control...
  24. ncbi request reprint Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Epidemiol 60:294-9. 2007
    ..To determine the validity of self-reported hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV-infected injection drug users (IDUs) vs. nonIDUs...
  25. pmc Randomized, controlled trial of therapy interruption in chronic HIV-1 infection
    Emmanouil Papasavvas
    The Wistar Institute, Philadelphia, Pennsylvania, USA
    PLoS Med 1:e64. 2004
    ....
  26. ncbi request reprint Adherence to HIV drug therapy
    Robert Gross
    University of Pennsylvania, USA
    LDI Issue Brief 8:1-4. 2002
    ..This Issue Brief summarizes recent work on the effect of adherence on short-term outcomes, and the ability of providers to predict and estimate their patients' adherence to therapy...
  27. ncbi request reprint Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 44:344-50. 2007
    ..Clinical observations suggest that patients with HIV/hepatitis C virus (HCV) may lose body weight during dual therapy, but this has not been confirmed analytically...
  28. ncbi request reprint Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 44:315-20. 2007
    ..The prevalence of occult HBV in HIV-infected patients remains controversial, and the risk factors and clinical significance are unknown...
  29. pmc Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial
    Robert Gross
    Department of Medicine Infectious Diseases, Center for Clinical Epidemiology and Biostatistics, and Center for Education and Research in Therapeutics, Univ of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Arch Intern Med 169:1224-32. 2009
    ..Success of antiretroviral therapy depends on high rates of adherence, but few interventions are effective. Our objective was to determine if modified directly observed therapy (mDOT) improves initial antiretroviral success...
  30. ncbi request reprint Acceptance of hepatitis B vaccination by pregnant adolescents
    Marilyn Stringer
    School of Nursing, University of Pennsylvania, Philadelphia, USA
    MCN Am J Matern Child Nurs 31:54-60. 2006
    ....
  31. ncbi request reprint Natural history of patients with low-level HIV viremia on antiretroviral therapy
    Vincent Lo Re
    Division of Infectious Diseases, Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    AIDS Patient Care STDS 18:436-42. 2004
    ..Higher initial HIV RNA levels and white race were predictors for virologic increase...
  32. pmc Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy
    Gregory P Bisson
    Department of Medicine, Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
    PLoS Med 5:e109. 2008
    ....
  33. ncbi request reprint Use of pharmacy refill data as a measure of antiretroviral adherence
    Robert Grossberg
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 804 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    Curr HIV/AIDS Rep 4:187-91. 2007
    ..Given the utility of this adherence measurement, it is likely that pharmacy refill will be the method of choice for measuring antiretroviral adherence in an increasing number of clinical and research settings...
  34. ncbi request reprint Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector
    Gregory P Bisson
    Division of Infectious Disease, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    AIDS 20:1333-6. 2006
    ..001]. HAART costs should be minimized as scale-up efforts in sub-Saharan Africa progress...
  35. ncbi request reprint Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals
    Joseph Graham
    Department of Family Medicine and Community Health, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    AIDS Behav 11:385-92. 2007
    ..Although the beliefs assessed do not mediate the relation between literacy and adherence, we identified low adherence norms as a potentially modifiable belief associated with adherence...
  36. pmc Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study
    Catherine S Parker
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 717 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
    J Gen Intern Med 22:1254-9. 2007
    ..Patient adherence to warfarin may influence anticoagulation control; yet, adherence among warfarin users has not been rigorously studied...
  37. ncbi request reprint Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy
    Robert Gross
    Division on of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    AIDS 16:1835-7. 2002
    ..Therefore, HAART should not be withheld solely on provider predictions of adherence. Providers should not rely on their own assessments when attempting to determine if patients are adhering to therapy...
  38. ncbi request reprint Effect of GB virus C viremia on HIV acquisition and HIV set-point
    Gregory P Bisson
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    AIDS 19:1910-2. 2005
    ..32; 95% confidence interval 0.6-2.6). Pre-existing GBV-C viremia at the time of HIV acquisition was also not associated with lower plasma HIV-RNA levels...
  39. pmc Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana
    N M Zetola
    Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Int J Tuberc Lung Dis 16:1529-34. 2012
    ..Data on alcohol abuse as a risk factor for the development of multidrug-resistant tuberculosis (MDR-TB) are scarce...
  40. doi request reprint Racial disparities in hypertension control, but not treatment intensification
    Craig A Umscheid
    Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Hypertens 23:54-61. 2010
    ..The objective of this study was to examine whether provider management of uncontrolled hypertension differed by patient race...
  41. ncbi request reprint Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study
    M A Bachhuber
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6021, USA
    Int J Tuberc Lung Dis 13:1038-40. 2009
    ..76; 95% credibility interval 0.6-0.95)...
  42. ncbi request reprint Epidemiologic studies of adverse effects of anti-retroviral drugs: how well is statistical power reported
    Scott D Halpern
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Pharmacoepidemiol Drug Saf 14:155-61. 2005
    ..To determine whether there is a difference in average statistical power between pharmacoepidemiologic studies of anti-retroviral adverse drug effects (ADEs) sponsored by for-profit versus non-profit organizations...
  43. ncbi request reprint Monitoring of long-term toxicities of HIV treatments: an international perspective
    Greg Bisson
    AIDS 17:2407-17. 2003
  44. ncbi request reprint The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses
    Bernard Vrijens
    AARDEX Ltd, Zug, Switzerland
    Basic Clin Pharmacol Toxicol 96:225-7. 2005
    ..With the broadening use of electronic monitoring to estimate longitudinal drug exposure, the need exists for an explicit discipline that concerns itself with "what the patient does with the drug". It is called Pharmionics...
  45. ncbi request reprint Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211
    Roy M Gulick
    Weill Medical College of Cornell University, New York, New York, NY, USA
    J Infect Dis 196:304-12. 2007
    ..Vicriviroc, an investigational CCR5 inhibitor, demonstrated short-term antiretroviral activity in a phase 1 study...
  46. ncbi request reprint HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211
    Timothy J Wilkin
    Division of International Medicine and Infectious Diseases, Weill Cornell Medical College, New York, NY, USA
    Clin Infect Dis 44:591-5. 2007
    ..Chemokine coreceptor use impacts both the natural history of human immunodeficiency virus type 1 (HIV-1) disease and the potential use of a new class of antiretroviral agents, the CCR5 inhibitors...

Research Grants9

  1. ADHERENCE TO PROTEASE INHIBITORS IN HIV
    Robert Gross; Fiscal Year: 2003
    ..abstract_text> ..
  2. Pharmacogenetics and HIV treatment outcomes
    Robert Gross; Fiscal Year: 2009
    ..Ultimately, the goal is to tailor HIV drug regimens to individual patients' metabolic profile with the result being improved outcomes in HIV disease, and ultimately, improved public health. ..
  3. Managed problem solving: An HIV adherence trial
    Robert Gross; Fiscal Year: 2009
    ..If successful, this intervention will not only result in improved clinical outcomes in individuals who take part, but may also decrease the emergence of resistant HIV if incorporated into standard of care for HIV management. ..
  4. Pharmacogenetics and HIV treatment outcomes
    Robert Gross; Fiscal Year: 2010
    ..Ultimately, the goal is to tailor HIV drug regimens to individual patients'metabolic profile with the result being improved outcomes in HIV disease, and ultimately, improved public health. ..
  5. Pharmacogenetics and HIV treatment outcomes
    Robert Gross; Fiscal Year: 2010
    ..Ultimately, the goal is to tailor HIV drug regimens to individual patients'metabolic profile with the result being improved outcomes in HIV disease, and ultimately, improved public health. ..